1. Home
  2. ALLE vs RVTY Comparison

ALLE vs RVTY Comparison

Compare ALLE & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegion plc

ALLE

Allegion plc

HOLD

Current Price

$167.34

Market Cap

13.9B

ML Signal

HOLD

Logo Revvity Inc.

RVTY

Revvity Inc.

HOLD

Current Price

$103.22

Market Cap

13.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLE
RVTY
Founded
2013
1937
Country
Ireland
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
13.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALLE
RVTY
Price
$167.34
$103.22
Analyst Decision
Hold
Buy
Analyst Count
9
14
Target Price
$170.33
$110.38
AVG Volume (30 Days)
878.3K
1.6M
Earning Date
02-18-2026
02-02-2026
Dividend Yield
1.23%
0.26%
EPS Growth
13.70
N/A
EPS
7.39
2.07
Revenue
$3,979,700,000.00
$2,856,051,000.00
Revenue This Year
$10.07
$4.69
Revenue Next Year
$6.33
$5.72
P/E Ratio
$22.40
$52.05
Revenue Growth
6.87
3.67
52 Week Low
$116.57
$81.36
52 Week High
$180.68
$126.57

Technical Indicators

Market Signals
Indicator
ALLE
RVTY
Relative Strength Index (RSI) 57.95 41.51
Support Level $162.42 $101.70
Resistance Level $168.58 $118.21
Average True Range (ATR) 3.14 4.06
MACD 0.12 -1.38
Stochastic Oscillator 72.53 7.89

Price Performance

Historical Comparison
ALLE
RVTY

About ALLE Allegion plc

Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.

About RVTY Revvity Inc.

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Share on Social Networks: